Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cyteir Therapeutics Inc (CYT)

Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cyteir Therapeutics Inc 99 HAYDEN AVE. BUILDING B SUITE 450 LEXINGTON MA 02421 USA

www.cyteir.com P: 857-285-4140

Description:

Cyteir Therapeutics Inc. is a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer. Cyteir Therapeutics Inc. is based in LEXINGTON, Mass.

Key Statistics

Overview:

Market Capitalization, $K 108,714
Enterprise Value, $K -38,406
Shares Outstanding, K 35,998
Annual Sales, $ 0 K
Annual Net Income, $ -46,060 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,530 K
EBIT, $ -38,250 K
EBITDA, $ -37,580 K
60-Month Beta 0.10
% of Insider Shareholders 14.40%
% of Institutional Shareholders 38.65%
Float, K 30,814
% Float 85.60%
Short Volume Ratio 0.28

Growth:

1-Year Return 101.33%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 11/06/23
Latest Earnings Date 03/28/24
Earnings Per Share ttm -0.94
EPS Growth vs. Prev Qtr 58.33%
EPS Growth vs. Prev Year 67.74%
Annual Dividend Yield 0.00%
Next Ex-Dividends Date 11/06/15
Dividend Payout Ratio 0.00%

CYT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -24.88%
Return-on-Assets % -23.83%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.87
Book Value/Share 3.46
Interest Coverage -2.40
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar